coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Dartford Model PCN, Dartford · Health Inequalities Profile

    PCN U17834 · NHS Kent and Medway Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    33,248

    Registered population

    61.4% aged 18–64

    16.0%

    Aged 65+

    ICB 19.9% · England 17.9%

    28.4%

    Ethnic minority (non-White)

    11.0% Asian · England 9.6%

    12.3%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~3,553

    Core20 residents (est.)

    Resident basis; registered basis ~4,109 · see page 3

    5,711

    Hypertension register

    -1.70% in 3 yrs · England +5.60%

    299

    SMI register

    27% of Dartford's

    652

    COPD register

    Reviews -9.15% in 3 yrs

    Forecast to 2030

    5,906

    Hypertension patients, 2030

    +195 on today

    68.6%

    QRISK ≥20% on statins, 2030

    -0.57pp over 3 yrs

    3.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    72.3%
    Age-5 MMR2 coverage trails first dose.

    In Q1 2025/26, age-5 MMR2 coverage is 72.3% (England 82.8%), 16.9 pp below MMR1 (89.2%), which may reflect recall gaps to verify locally.

    61.6%
    Heart failure annual reviews fell sharply.

    Annual heart failure reviews reach 61.6% (Dartford 69.6%, ICB 75.0%, England 78.5%) and fell 20.7% over 2023 to 2025 against England (+8.7%).

    80.9%
    Diabetes statin prescribing exceeds national benchmarks.

    Statin therapy in diabetes reaches 80.9% without CVD (Dartford 73.8%, ICB 72.0%, England 73.2%) and 87.5% with CVD (England 84.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger, diverse population coincides with expanding learning disability registers and care beds

    Across 33,248 registered patients in three practices, 22.6% are aged 0-17 (Dartford 23.3%, ICB 20.7%, England 19.6%) and 16.0% are aged 65+ (Dartford 15.1%, ICB 19.9%, England 17.9%). Practice scale spans 7,456 to 15,087 patients. Area Census estimates for usual residents in associated areas indicate a 28.4% ethnic minority share, including 11.8% Black (Dartford 10.5%, ICB 3.1%, England 4.2%) and 11.0% Asian residents (Dartford 9.9%, ICB 4.7%, England 9.6%).

    Age profile

    0–1722.6%
    18–6461.4%
    65+16.0%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White71.6%
    Black11.8%
    Asian11.0%
    Mixed3.4%
    Other2.3%

    Older people · falls rows are Dartford local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Dartford LA)2,0062,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.1%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.7%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Dartford LA)1,0009819552024/25
    Falls deaths, all ages, per 100,000 (Dartford LA)14.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    PCN Core20 share is 12.3%, but practice shares span 18.6 percentage points

    The PCN Core20 share of registered patients is 12.3%, below England (21.0%) and NHS Kent and Medway ICB (17.1%), but above Dartford (9.8%). However, practice shares span 18.6 percentage points: Lowfield Medical Centre has the highest concentration at 24.86% (1,854 estimated Core20 patients), while Dr Cj Shimmins & Partners has 10.53% (1,589 estimated patients) and The Wellcome Practice has 6.22% (666 estimated patients). Resident estimates (3,553) and registered sums (4,109) differ by population base. Prioritising support solely by concentration risks overlooking large patient volumes.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Lowfield24.9% · 1,854 patients
    Dr Cj Shimmins &10.5% · 1,589 patients
    Wellcome6.2% · 666 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    299

    SMI register

    0.87% recorded prevalence

    191

    Learning disability register

    0.56% recorded prevalence

    13

    Care homes, 625 beds

    In the PCN catchment

    8.6%

    Provide unpaid care

    Dartford, Census 2021

    Recorded severe mental illness covers 299 patients (0.9%; Dartford 0.8%, ICB 0.9%, England 1.0%). The learning disability register has 191 patients (0.6%), rising +15.3% over 2023 to 2025 (Dartford -1.6%, ICB +4.5%, England +5.4%). The catchment includes 13 care homes with 625 beds (occupancy and resident registrations unrecorded). Faster learning disability register growth than England prioritises structured annual health check capacity.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 0.9%. Annual blood pressure checks reached 75.9%, below England (83.4%) and Dartford (78.5%), and 65.6% at Dr Cj Shimmins & Partners, while BMI checks reached 80.6%. Focused recall could help close recorded blood pressure check disparities.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,711

    Hypertension register

    −1.70%

    Register growth, 3 yrs

    Dartford +7.12% · England +5.60%

    −3.99pp

    BP control, under 80

    ≤140/90 · +2.14pp aged 80+

    +195

    More patients by 2030

    Forecast 5,906 (16.07%)

    Hypertension case-finding and control

    Hypertension QOF prevalence is 16.6% (5,711 patients), exceeding England (15.2%), Dartford (15.9%) and NHS Kent and Medway ICB (16.2%), though prevalence fell 1.7% over 2023 to 2025 (England +5.6%). Under-80 blood pressure control is 65.6%, trailing England (67.8%) after falling 5.7% (England +3.2%), spanning from 62.1% at Dr Cj Shimmins & Partners to 70.5% at Lowfield Medical Centre, whereas over-80 control reached 84.5% (England 81.2%). Heart failure annual reviews fell 20.7% to 61.6% (England 78.5%, +8.7%). Denominators include personalised care adjustments. Trailing under-80 blood pressure control and falling heart failure reviews indicate room to review proactive recall and monitoring across practices.

    Lipids and statins

    Lipid-lowering therapy reaches 69.7% for patients with QRISK ≥ 20% (England 63.6%), with diabetes statin coverage at 80.9% without CVD (England 73.2%) and 87.5% with CVD (England 84.4%). QRISK therapy fell 0.8% over 2023 to 2025 (England +6.2%). Stronger statin uptake than England provides an opportunity to maintain primary prevention while addressing slower three-year growth.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202648,752£2.00£1.90£1.86£97,504
    Cardiovascular (all), 202560,133£3.99£3.57£3.33£239,931

    For lipid-regulating drugs in 2026, the PCN prescribed 48,752 items at £2.00 per item, compared to £1.86 in England, £1.79 in Dartford, and £1.90 in NHS Kent and Medway ICB, spending £6,825 more than at England's unit cost. This unit-cost indicator reflects formulary mix rather than realized inefficiency, as unit cost does not evaluate case-mix.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.47%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −2.18%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 5.5% (register 1,788), but 12-month reviews reached 58.0%, below England (65.7%) and Dartford (60.8%), leaving about 750 patients unreviewed; practice rates range from 50.1% at Dr Cj Shimmins & Partners to 74.6% at Lowfield Medical Centre. For ages 5 to 19, asthma prescribing is 838 items per 1,000 (England 1,488). COPD reviews fell 9.2% over 2023 to 2025 (England +2.8%) to 66.4% (England 76.4%). Proactive respiratory review recall is needed across all practices to reverse declining review coverage.

    Cancer register and children's immunisation

    Cancer prevalence is 3.2% (1,105 patients; England 3.8%). In Q1 2025/26, complete 6-in-1 immunisation at 24 months reached 97.5%, exceeding the 95.0% target by 2.5 pp. Conversely, at age 5, MMR dose 2 and 4-in-1 booster coverage were both 72.3%, trailing the target by 22.7 pp with an MMR dose drop of 16.9 pp across the PCN. Prioritising pre-school booster call and recall is required to restore secondary coverage before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.0%

    England 91.0%

    6-in-1 complete primary course at 24 months97.5%

    England 92.2%

    MMR dose 1 at 24 months88.6%

    England 88.3%

    MMR dose 2 at age 572.3%

    England 82.8%

    4-in-1 pre-school booster at age 572.3%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    Across NHS Kent and Medway ICB in 2022, 55.6% of cancers with a known stage were diagnosed at stage 1 or 2 (4,661 of 8,384 cases), compared with England (55.3%) and 19.4 pp below the 75.0% national ambition. Reaching 75.0% would require about 1,630 additional early-stage diagnoses annually across the ICB. Known-stage share was 63.6% (England 67.0%). Within Dartford Model PCN, cervical screening coverage aged 25-49 is 67.4% (ICB 69.9%, England 66.8%), falling to 64.6% at Dr Cj Shimmins & Partners. Lower screening uptake could contribute to delayed detection across wider system pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional data for Jul 2026, Dartford and Gravesham NHS Trust achieved 63.6% on the 62-day cancer referral to treatment standard, trailing King's College Hospital NHS Foundation Trust (70.1%), England (71.2%), and NHS Kent and Medway Integrated Care Board (75.9%), sitting 21.4 pp below the 85.0% standard. The trust met the 28-day faster diagnosis standard at 78.1% (standard 75.0%) and the 31-day combined treatment standard at 97.5% (standard 96.0%). For diagnostic tests in Jul 2026, 8.4% of patients waited 6+ weeks at the trust (England 23.1%). These hospital figures reflect provider activity, not PCN-specific performance.

    Pathways within standard (%)Dartford and GraveshamKing's CollegeKent and Medway ICBEngland
    28-day faster diagnosis (75%)78.1480.6876.7879.32
    31-day treatment (96%)97.4896.6895.8492.50
    62-day referral to treatment (85%)63.5970.1575.9371.16
    Diagnostic waits over 6 weeks (%)Dartford and GraveshamKent HealthKing's CollegeEngland
    MRI0.36—21.2221.40
    CT2.08—22.609.92
    Echocardiography3.90—14.3928.48
    Colonoscopy0.40—41.8130.83
    Gastroscopy0.00—35.9829.02
    All 15 DM01 tests8.3727.4919.1523.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). Provisional experimental CSDS data for Jun 2026 record 210,170 community care contacts across Kent covering 60,605 patients, with 265,905 care activities. NHS Kent and Medway Integrated Care Board recorded 254,055 contacts and 297,595 activities. Older adults aged 65+ accounted for 65.8% of borough residents' contacts (138,250 of 210,170). These figures reflect regional provider activity, not unique PCN patient activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient experience varies by 24.3 pp across practices alongside marked differences in access

    In 2025/26, clinical QOF achievement was 99.7% at Lowfield Medical Centre and 100.0% at Dr Cj Shimmins & Partners and The Wellcome Practice (England 97.1%). Vaccination and immunisation achievement ranged from 15.6% at Dr Cj Shimmins & Partners and The Wellcome Practice to 20.8% at Lowfield Medical Centre (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Dr Cj Shimmins &8810.556.8%59.9%79.5%
    Wellcome1066.233.9%76.0%76.6%
    Lowfield11424.938.4%86.6%55.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNDartfordAssetPCNDartford
    Care homes (catchment)13 (625 beds)n/aSchools (catchment)70n/a
    Children's centres57Places of worship3141
    Libraries37Homelessness support (VCS)n/a1
    Day centres (VCS)55Children and young people (VCS)11
    Carers support groups (VCS)n/a3Primary schools (LA maintained)36
    Primary academies1422

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Proactive asthma annual review recall

    Asthma 12-month reviews (register 1,788) reached 58.0% (denominator incl. PCAs), below England (65.7%) by 7.6 pp and Dartford (60.8%) by 2.8 pp, leaving about 750 patients unreviewed. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school MMR2 and booster recall

    At age 5 in Q1 2025/26 (cohort 83), MMR2 and 4-in-1 coverage are both 72.3%, 22.7 pp below the 95.0% target and 16.9 pp below MMR1 (89.2%), with a 21.6 pp drop at Dr Cj Shimmins & Partners. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Diverse community health outreach (p2)Black / African / Caribbean / Black BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 resource allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health checks for SMI (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Under-eighty blood pressure recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Proactive asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Pre-school MMR2 and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15